Adage Capital Partners Gp, L.L.C. Arrowhead Pharmaceuticals, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$51 Billion
Q1 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $393,000 - $541,200	-15,000 Reduced 12.71%	103,035 $2.77 Million
Q2 2023 Aug 14, 2023	BUY	$25.16 - $41.38 $762,750 - $1.25 Million	30,316 Added 34.56%	118,035 $4.21 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $184,704 - $300,378	-7,800 Reduced 8.17%	87,719 $2.23 Million
Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $2.31 Million - $3.35 Million	82,620 Added 640.51%	95,519 $3.87 Million
Q2 2022 Aug 15, 2022	SELL	$27.79 - $50.61 $297,353 - $541,527	-10,700 Reduced 45.34%	12,899 $454,000

Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $4.61 Million - $8.14 Million	-116,401 Reduced 83.14%	23,599 $1.09 Million
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $583,800 - $849,599	-10,000 Reduced 6.67%	140,000 $8.74 Million
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $6.84 Million - $9.94 Million	110,000 Added 275.0%	150,000 $12.4 Million
Q1 2021 May 17, 2021	SELL	$61.35 - $90.47 $6.75 Million - $9.95 Million	-110,000 Reduced 73.33%	40,000 $2.65 Million
Q4 2020 Feb 16, 2021	BUY	$43.82 - $85.37 $2.19 Million - $4.27 Million	50,000 Added 50.0%	150,000 $11.5 Million
Q3 2020 Nov 16, 2020	SELL	$33.21 - $51.27 $830,250 - $1.28 Million	-25,000 Reduced 20.0%	100,000 $4.31 Million
Q2 2020 Aug 14, 2020	SELL	$26.12 - $43.27 $653,000 - $1.08 Million	-25,000 Reduced 16.67%	125,000 $5.4 Million
Q1 2020 May 15, 2020	SELL	$20.56 - $63.12 $513,999 - $1.58 Million	-25,000 Reduced 14.29%	150,000 $4.32 Million
Q4 2019 Feb 14, 2020	SELL	$28.14 - $73.01 $7.04 Million - $18.3 Million	-250,000 Reduced 58.82%	175,000 $11.1 Million
Q3 2019 Nov 14, 2019	SELL	$26.26 - $34.86 $11.8 Million - $15.7 Million	-450,000 Reduced 51.43%	425,000 $12 Million
Q2 2019 Aug 14, 2019	SELL	$17.43 - $28.82 $8.72 Million - $14.4 Million	-500,000 Reduced 36.36%	875,000 $23.2 Million
Q4 2018 Feb 14, 2019	BUY	$10.74 - $19.7 $5.1 Million - $9.36 Million	475,000 Added 52.78%	1,375,000 $17.1 Million
Q3 2018 Nov 14, 2018	SELL	$14.0 - $20.3 $8.45 Million - $12.3 Million	-603,500 Reduced 40.14%	900,000 $17.3 Million
Q1 2018 May 15, 2018	BUY	$3.72 - $7.64 $5.59 Million - $11.5 Million	1,503,500 New	1,503,500 $10.8 Million

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account